Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study.
Helen StrongmanSolomon ChristopherMaila MajakRachael WilliamsShahram BahmanyarMarie LinderEdith M HeintjesDimitri BennettPasi KorhonenFabian HotiPublished in: BMJ open diabetes research & care (2018)
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP; EUPAS3626).